.png){kind=logo}
Value stocks offer good opportunities for long-term investment in 2025, especially for investors who want stability and growth. Value stocks usually have lower price-to-earnings (P/E) ratios and good fundamentals. So, they are mostly preferred by investors who want to match risk with return.
Let’s explore the value stocks for long-term investments in 2025, as of April 1, 2025:
Pfizer is a pharma giant with a wide portfolio of drugs and vaccines. The company's focus on research and development points towards a bright future. With a decent P/E ratio of around 8.5 and a decent dividend yield of 4.2%, Pfizer is a value stock with solid fundamentals.
Campbell Soup Company, which operates with famous food brands, has been resilient within the consumer staples industry. At a P/E ratio of about 12.0 and dividend yield of 3.0%, it has stable earnings and fair valuation statistics, making it a good candidate for value investors.
Nike's strong brand recognition and global leadership in the athletic clothing market account for its high financial performance. Although with a higher P/E ratio of about 25.0, its growth opportunity and market leadership make it a worthwhile investment for investors. Nike's dividend yield is about 1.0%, indicating a moderate value investment strategy.
Huntington Ingalls is the largest independent American shipbuilder of military vessels. The firm enjoys long-term defense contracts, which underpin its consistent earnings. With a P/E ratio of about 15.0 and a dividend yield of 2.5%, Huntington Ingalls provides an attractive value proposition within the defense industry.
Constellation Brands, a large cap in the alcohol beverage sector, has a diverse portfolio of premium brands. Its P/E of around 18.0 and dividend yield of 1.8% are indicative of its solid market position and stable financial performance. The company's emphasis on premium brands and selective acquisitions make it a good value stock.
Famous for brands such as Jack Daniel's, Brown-Forman has a long history in the spirits business. With a P/E ratio of around 20.0 and a dividend yield of 1.5%, the company's steady performance and focus on quality make it a good value investment.
Alphabet, the parent of Google, has a stranglehold on digital advertising and continues to increase its reach across diverse technology realms. At a P/E ratio of about 22.0, Alphabet presents substantial growth prospects. While it does not pay a dividend at present, Alphabet's solid market position and wise investments make it a good long-term gamble.
GSK, an international healthcare organization, has a sturdy dividend yield of 5.0% accompanied by a P/E ratio of around 10.0. Its diversified products portfolio and drive towards innovation, especially in growing markets, have it being the perfect candidate for value-driven investors.
Zimmer Biomet focuses on musculoskeletal healthcare with a variety of orthopedic products. It has close ties with healthcare professionals and creative solutions that are a factor in its market share. With a P/E ratio of around 14.0 and a dividend yield of 0.8%, Zimmer Biomet offers a sound value opportunity.
Danaher, an international science and technology leader, offers diversified products and services in different industries. Its strategic acquisitions and emphasis on innovation have fueled its growth path. With a P/E ratio of around 25.0 and a fairly low dividend yield of 0.6%, Danaher is a solid value stock player.
Investing in value stocks may be a smart strategy for long-term growth, promising potential capital appreciation and income through dividends. Still, investors should do their own thorough research to figure out how each stock fits in the personal investment plan.
